{"id":"W4412507859","doi":"10.1093/noajnl/vdaf160","title":"First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology Advances","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Bispecific antibody; Glioblastoma; Antibody; CD3; Cancer research; Medicine; Oncology; Internal medicine; Immunology; Monoclonal antibody; Immune system; CD8","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002192308,0.0001978045,0.0006597374,0.0004227179,0.00009391709,0.000005667614,0.0002919036,0.00008645701,0.00005812371],"category_scores_gemma":[0.00005311859,0.0001278313,0.0000903028,0.0006756864,0.0002613525,0.00008333322,0.00004616935,0.0002364316,0.00000376646],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007635722,"about_ca_system_score_gemma":0.0001130887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006801087,"about_ca_topic_score_gemma":0.01004266,"domain_scores_codex":[0.9980574,0.0003826655,0.0005522696,0.0003849869,0.0002986074,0.000324029],"domain_scores_gemma":[0.9980738,0.001258747,0.0001387638,0.000399428,0.00007060843,0.00005869521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005166447,0.03520653,0.8374655,0.0003665175,0.00007321438,0.002825203,0.007871361,0.0006354547,0.0844176,0.0004248236,0.0001580303,0.02538929],"study_design_scores_gemma":[0.01593541,0.06488651,0.7797357,0.0001247796,0.0001041295,0.00003269086,0.009314879,0.0002442112,0.02803374,0.0003860717,0.1010097,0.0001921474],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917386,0.001831191,0.000001645912,0.000970725,0.0001796315,0.001214833,0.00001080593,0.00001160917,0.004040976],"genre_scores_gemma":[0.9968185,0.002518957,0.00006679088,0.0001683836,0.00006848124,0.000105131,0.00001029802,0.00001048464,0.0002329017],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1008517,"threshold_uncertainty_score":0.5604041,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02170407105458333,"score_gpt":0.3771721298724504,"score_spread":0.355468058817867,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}